Identifíquese
¿Aún no es suscriptor de la revista?
Comprar el acceso al artículo
Comprando el artículo el pdf del mismo podrá ser descargado
Teléfono para incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
Bibliografía
[1]
Post-COVID Conditions [Internet]. Centers for Disease Control and Prevention. 2022 [Consultado 18 Jun 2023]. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.
[2]
F. Callard, E. Perego.
How and why patients made Long Covid.
Soc Sci Med., (2021), 268 pp. 113426
[3]
M. Fricker.
Injusticia epistémica.
Ed.Herder, (2017),
[4]
Organización Mundial de la Salud. Una definición de caso clínico de afección pos-COVID-19 por el proceso de consenso Delphi 6 de octubre de 2021. Organización Mundial de la Salud; 2021 [Consultado 18 Jun 2023]. Report No.: WHO/2019-nCoV/Post_COVID-19_condition/Clinical_case_definition/2021.1. Disponible en: https://apps.who.int/iris/handle/10665/349926.
[5]
Serra-Sutton V, Serrano-Blanco A, Torres M, Montané C, Solà I, Trejo A, et al. Grupo Motor del CIBERPOSTCOVID. Definición operativa de COVID persistente y sus elementos clave en el marco del CIBERPOSTCOVID. Informe Técnico. Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III, Agència de Qualitat i Avaluació Sanitàries de Catalunya, Parc Sanitari Sant Joan de Déu [citado 7 Dic 2022]. Disponible en: https://www.ciberisciii.es/media/3049157/informe-ciberpostcovid-castellano.pdf.
[6]
Ministerio de Sanidad, Consumo y Bienestar Social. Manual de Codificación CIE-10-ES Diagnósticos. 4.a ed. 2022. Disponible en: https://www.sanidad.gob.es/estadEstudios/estadisticas/normalizacion/CIE10/Manual_Cod_CIE_10_ ES_Diagn_4_Ed.pdf.
[7]
Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK - Office for National Statistics [Citado 18 Jun 2023]. Disponible en: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/30march2023.
[8]
M. Michelen, L. Manoharan, N. Elkheir, V. Cheng, A. Dagens, C. Hastie, et al.
Characterising long COVID: A living systematic review.
BMJ Global Health., (2021), 6 pp. e005427
[9]
A.V. Ballering, S.K.R.van Zon, T.C.olde Hartman, J.G.M. Rosmalen.
Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study.
Lancet., (2022), 400 pp. 452-461
[10]
K. Magnusson, A. Turkiewicz, S.A. Flottorp, M. Englund.
Prevalence of long COVID complaints in persons with and without COVID-19.
Sci Rep., (2023), 13 pp. 6074
[11]
R.R. Deer, M.A. Rock, N. Vasilevsky, L. Carmody, H. Rando, A.J. Anzalone, et al.
Characterizing long COVID: Deep phenotype of a complex condition.
EBioMedicine., (2021), 74 pp. 103722
[12]
H.E. Davis, L. McCorkell, J.M. Vogel, E.J. Topol, Long COVID:.
Major findings, mechanisms and recommendations.
Nat Rev Microbiol., (2023), 21 pp. 133-146
[13]
Dirección General de Salud Pública. Ministerio de Sanidad. Actualización n.o 650. Enfermedad por el coronavirus (COVID-19). 31 Mar 2023. Disponible en: https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/Actualizacion_665_COVID-19.pdf.
[14]
T. Greenhalgh, M. Sivan, B. Delaney, R. Evans, R. Milne.
Long covid—an update for primary care.
BMJ., (2022), 378 pp. e072117
[15]
E.L. Menéndez Torre, J. Ares Blanco, S. Conde Barreiro, G. Rojo Martínez, E. Delgado Alvarez.
en representación del Grupo de Epidemiología de la Sociedad Española de Diabetes (SED). Prevalence of diabetes mellitus in Spain in 2016 according to the Primary Care Clinical Database (BDCAP).
Endocrinol Diabetes Nutr (Engl Ed), (2021), 68 pp. 109-115
[16]
C.H. Sudre, B. Murray, T. Varsavsky, M.S. Graham, R.S. Penfold, R.C. Bowyer, et al.
Attributes and predictors of long COVID.
Nat Med., (2021), 27 pp. 626-631
[17]
C. Fernández-de-las-Peñas, J.D. Martín-Guerrero, Pellicer-Valero ÓJ, E. Navarro-Pardo, V. Gómez-Mayordomo, M.L. Cuadrado, et al.
Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: The LONG-COVID-EXP-CM multicenter study.
J Clin Med., (2022), 11 pp. 413
[18]
R. Jones, A. Davis, B. Stanley, S. Julious, D. Ryan, D.J. Jackson, et al.
Risk predictors and symptom features of long COVID within a broad primary care patient population including both tested and untested patients.
Pragmat Obs Res., (2021), 12 pp. 93-104
[19]
E.J. Thompson, D.M. Williams, A.J. Walker, R.E. Mitchell, C.L. Niedzwiedz, T.C. Yang, et al.
Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records.
Nat Commun., (2022), 13 pp. 3528
[20]
H.E. Davis, G.S. Assaf, L. McCorkell, H. Wei, R.J. Low, Y. Re’em, et al.
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact.
EClinical-Medicine., (2021), 38 pp. 101019
[21]
E. Pretorius, C. Venter, G.J. Laubscher, M.J. Kotze, S.O. Oladejo, L.R. Watson, et al.
Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID/post-acute sequelae of COVID-19 (PASC).
Cardiovasc Diabetol., (2022), 21 pp. 148
[22]
Klein J, Wood J, Jaycox J, Lu P, Dhodapkar RM, Gehlhausen JR, et al. Distinguishing features of Long COVID identified through immune profiling. medRxiv. 2022;2022.08.09.22278592.
[23]
R. Kaur, G. Chupp.
Phenotypes and endotypes of adult asthma: Moving toward precision medicine.
J Allergy Clin Immunol., (2019), 144 pp. 1-12
[24]
S.R. Stein, S.C. Ramelli, A. Grazioli, J.Y. Chung, M. Singh, C.K. Yinda, et al.
SARS-CoV-2 infection and persistence in the human body and brain at autopsy.
Nature., (2022), 612 pp. 758-763
[25]
Z. Swank, Y. Senussi, Z. Manickas-Hill, X.G. Yu, J.Z. Li, G. Alter, et al.
Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae.
Clin Infect Dis., (2023), 76 pp. e487-e490
[26]
A. Iwasaki, D. Putrino.
Why we need a deeper understanding of the pathophysiology of long COVID.
Lancet Infect Dis., (2023), 23 pp. 393-395
[27]
A. Fernández-Castañeda, P. Lu, A.C. Geraghty, E. Song, M.H. Lee, J. Wood, et al.
Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation.
Cell., (2022), 185
[28]
E.Y. Wang, T. Mao, J. Klein, Y. Dai, J.D. Huck, J.R. Jaycox, et al.
Diverse functional autoantibodies in patients with COVID-19.
Nature., (2021), 595 pp. 283-288
[29]
M.J. Peluso, T.M. Deveau, S.E. Munter, D. Ryder, A. Buck, G. Beck-Engeser, et al.
Chronic viral coinfections differentially affect the likelihood of developing long COVID.
J Clin Invest., (2023), 133 pp. e163669
[30]
D. Castanares-Zapatero, P. Chalon, L. Kohn, M. Dauvrin, J. Detollenaere, C. Maertens de Noordhout, et al.
Pathophysiology and mechanism of long COVID: A comprehensive review.
Ann Med., (2022), 54 pp. 1473-1487
[31]
J. Choutka, V. Jansari, M. Hornig, A. Iwasaki.
Unexplained post-acute infection syndromes.
Nat Med., (2022), 28 pp. 911-923
[32]
D.B. Kell, G.J. Laubscher, E. Pretorius.
A central role for amyloid fibrin microclots in long COVID/PASC: Origins and therapeutic implications.
Biochem J., (2022), 479 pp. 537-559
[33]
J.P. Haran, E. Bradley, A.L. Zeamer, L. Cincotta, M.C. Salive, P. Dutta, et al.
Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID.
JCI Insight., (2021), 6 pp. e152346
[34]
Y.K. Yeoh, T. Zuo, G.C.Y. Lui, F. Zhang, Q. Liu, A.Y. Li, et al.
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
Gut., (2021), 70 pp. 698-706
[35]
A.D. Proal, M.B. VanElzakker.
Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms.
Front Microbiol., (2021),
[36]
Y. Su, D. Yuan, D.G. Chen, R.H. Ng, K. Wang, J. Choi, et al.
Multiple early factors anticipate post-acute COVID-19 sequelae.
Cell., (2022), 185
[37]
K.J.G. Díaz-Resendiz, A.B. Benitez-Trinidad, C.E. Covantes-Rosales, G.A. Toledo-Ibarra, P.C. Ortiz-Lazareno, D.A. Girón-Pérez, et al.
Loss of mitochondrial membrane potential (Δ¿m) in leucocytes as post-COVID-19 sequelae.
J Leukoc Biol., (2022), 112 pp. 23-29
[38]
A. Pozzi.
COVID-19 and mitochondrial non-coding RNAs: New insights from published data.
Front Physiol., (2021), 12 pp. 805005
[39]
A.M. O’Hare, E.K. Vig, T.J. Iwashyna, A. Fox, J.S. Taylor, E.M. Viglianti, et al.
Complexity and challenges of the clinical diagnosis and management of long COVID.
JAMA Netw Open, (2022), 5 pp. e2240332
[40]
Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 Long-term effects of COVID-19: A systematic review and meta-analysis. medRxiv. 2021;2021.01.27.21250617.
[41]
S.A.M. Van Kessel, T.C. Olde Hartman, P.L.B.J. Lucassen, C.H.M. van Jaarsveld.
Post-acute and long-COVID-19 symptoms in patients with mild diseases: A systematic review.
Fam Pract., (2022), 39 pp. 159-167
[42]
V.T. Tran, R. Porcher, I. Pane, P. Ravaud.
Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort.
Nat Commun., (2022), 13 pp. 1812
[43]
Prieto-Alhambra D, Kostka K, Roel E, Trinh N, Delmestri A, Mateu L, et al.The burden of long COVID: A multinational cohort analysis of Spanish and UK data including SARS-CoV-2 infections, reinfections, and matched contemporaneous test negative controls. Research square. 27 Abr 2023 [Consultado 18 Jun 2023]. Disponible en: https://www.ndorms.ox.ac.uk/publications/1339152.
[44]
M. Whitaker, J. Elliott, M. Chadeau-Hyam, S. Riley, A. Darzi, G. Cooke, et al.
Persistent COVID-19 symptoms in a community study of 606,434 people in England.
Nat Commun., (2022), 13 pp. 1957
[45]
N. Ziauddeen, D. Gurdasani, M.E. O’Hara, C. Hastie, P. Roderick, G. Yao, et al.
Characteristics and impact of Long Covid: Findings from an online survey.
PLoS One., (2022), 17 pp. e0264331
[46]
I. Singh, P. Joseph, P.M. Heerdt, M. Cullinan, D.D. Lutchmansingh, M. Gulati, et al.
Persistent exertional intolerance after COVID-19: Insights from invasive cardiopulmonary exercise testing.
Chest., (2022), 161 pp. 54-63
[47]
M.S. Durstenfeld, K. Sun, P. Tahir, M.J. Peluso, S.G. Deeks, M.A. Aras, et al.
Use of cardiopulmonary exercise testing to evaluate long COVID-19 symptoms in adults: A systematic review and meta-analysis.
JAMA Netw Open, (2022), 5 pp. e2236057
[48]
A. Bilgin, G. Kesik, L. Ozdemir.
‘The body seems to have no life’: The experiences and perceptions of fatigue among patients after COVID-19.
J Clin Nurs., (2021),
[49]
NCI. Fatigue. 2023 [Consultado 18 Jun 2023]. Disponible en: https://www.cancer.gov/about-cancer/treatment/side-effects/fatigue/fatigue-pdq.
[50]
Fatiga. Diccionario médico. Clínica Universidad de Navarra. 2023 [Consultado 18 Jun 2023]. Disponible en: https://www.cun.es/diccionario-medico/terminos/fatiga.
[51]
R. Twomey, J. DeMars, K. Franklin, S.N. Culos-Reed, J. Weatherald, J.G. Wrightson.
Chronic fatigue and post exertional malaise in people living with long COVID: An observational study.
Phys Ther., (2022), 102 pp. pzac005
[52]
F.A. Klok, G.J.A.M. Boon, S. Barco, M. Endres, J.J.M. Geelhoed, S. Knauss, et al.
The post-COVID-19 Functional Status Scale: A tool to measure functional status over time after COVID-19.
Eur Respir J., (2020), 56 pp. 2001494
[53]
M. Sivan, N. Preston, A. Parkin, S. Makower, J. Gee, D. Ross, et al.
The modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) patient-reported outcome measure for Long;1; Covid or Post-COVID-19 syndrome.
J Med Virol., (2022), 94 pp. 4253-4264
[54]
Treating the Most Disruptive Symptoms First and Preventing Worsening of Symptoms | Clinical Care of Patients | Healthcare Providers | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | CDC. 2021 [Consultado 18 Jun 2023]. Disponible en: https://www.cdc.gov/me-cfs/healthcare-providers/clinical-care-patients-mecfs/treating-most-disruptive-symptoms.html.
[55]
A.B. Espinosa-Gonzalez, H. Master, N. Gall, S. Halpin, N. Rogers, T. Greenhalgh.
Orthostatic tachycardia after covid-19.
BMJ., (2023), 380 pp. e073488
[56]
D. Mallick, L. Goyal, P. Chourasia, M.R. Zapata, K. Yashi, S. Surani.
COVID-19 induced postural orthostatic tachycardia syndrome (POTS): A review.
Cureus., (2023), 15 pp. e36955
[57]
Davis H. Brain fog, phantom smells and tinnitus: My experience as a Covid ‘long hauler’. The Guardian. 2020 Aug 5 [Consultado 18 Jun 2023]. Disponible en: https://www.theguardian.com/commentisfree/2020/aug/05/brain-fog-phantom-smells-and-tinnitus-my-experience-as-a-covid-long-hauler.
[58]
Definition of neurocognitive - NCI Dictionary of Cancer Terms - NCI [Internet]. 2011 [Consultado 18 Jun 2023]. Disponible en: https://www.cancer.gov/publications/dictio-naries/cancer-terms/def/neurocognitive.
[59]
A. Subramanian, K. Nirantharakumar, S. Hughes, P. Myles, T. Williams, K.M. Gokhale, et al.
Symptoms and risk factors for long COVID in non-hospitalized adults.
Nat Med., (2022), 28 pp. 1706-1714
[60]
G. Jennings, A. Monaghan, F. Xue, E. Duggan, R. Romero-Ortuño.
Comprehensive clinical characterisation of brain fog in adults reporting long COVID symptoms.
J Clin Med., (2022), 11 pp. 3440
[61]
G. Douaud, S. Lee, F. Alfaro-Almagro, C. Arthofer, C. Wang, P. McCarthy, et al.
SARS-CoV-2 is associated with changes in brain structure in UK Biobank.
Nature., (2022), 604 pp. 697-707
[62]
P. Guo, A. Benito Ballesteros, S.P. Yeung, R. Liu, A. Saha, L. Curtis, et al.
COVCOG 2: Cognitive and memory deficits in long COVID: A second publication from the COVID and cognition study.
Front Aging Neurosci., (2022), 14 pp. 804937
[63]
G.A. De Erausquin, H. Snyder, M. Carrillo, A.A. Hosseini, T.S. Brugha, S. Seshadri, et al.
The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning.
Alzheimers Dement., (2021), 17 pp. 1056-1065
[64]
Bateman Horne Center. Long COVID provider & patient resources. 2020. [Consultado 18 Jun 2023]. Disponible en: https://batemanhornecenter.org/education/long-covid/.
[65]
C. Callan, E. Ladds, L. Husain, K. Pattinson, T. Greenhalgh.
‘I can’t cope with multiple inputs’: A qualitative study of the lived experience of ‘brain fog’ after COVID-19.
BMJ Open., (2022), 12 pp. e056366
[66]
A.L. Stenhoff, S. Sadreddini, S. Peters, A. Wearden.
Understanding medical students’ views of chronic fatigue syndrome: A qualitative study.
J Health Psychol., (2015), 20 pp. 198-209
[67]
M. Garg, M. Maralakunte, S. Garg, S. Dhooria, I. Sehgal, A.S. Bhalla, et al.
The Conundrum of ‘Long-COVID-19’: A narrative review.
Int J Gen Med., (2021), 14 pp. 2491-2506
[68]
A. Dennis, D.J. Cuthbertson, D. Wootton, M. Crooks, M. Gabbay, N. Eichert, et al.
Multi-organ impairment and long COVID: A 1-year prospective, longitudinal cohort study.
J R Soc Med., (2023), 116 pp. 97-112
[69]
M.M. Hossain, J. Das, F. Rahman, F. Nesa, P. Hossain, A.M. Khairul Islam, et al.
Living with “long COVID”: A systematic review and meta-synthesis of qualitative evidence.
PLos One., (2023), 18 pp. e0281884
[70]
N.J. Devlin, R. Brooks.
EQ-5D and the EuroQol Group: Past, present and future.
Appl Health Econ Health Policy, (2017), 15 pp. 127-137
[71]
E. Asaba, M. Sy, R.C. Pineda, R. Aldrich, T. Anzai, P. Bontje, et al.
Return to work after COVID-19: An international perspective.
World Fed Occup Ther Bull., (2023), 79 pp. 42-52
[72]
K.K. O’Brien, D.A. Brown, C. Bergin, K.M. Erlandson, J.H. Vera, L. Avery, et al.
Long COVID and episodic disability: Advancing the conceptualisation, measurement and knowledge of episodic disability among people living with Long COVID - protocol for a mixed-methods study.
BMJ Open., (2022), 12 pp. e060826
[73]
DeMars J, O’Brien KK, Major A, Graham K, Goulding S, Brown DA, et al. Recommendations for employers, insurers, human resource personnel and rehabilitation professionals on return to work for people living with long COVID. Canada: December 1, 2022 [Consultado 24 Jun 2023]. Disponible en: https://www.realizecanada.org/wp-content/uploads/Recommendations-for-RtW-doc-final.pdf.
[74]
A.V. Raveendran, R. Jayadevan, S. Sashidharan.
Long COVID: An overview.
Diabetes Metab Syndr., (2021), 15 pp. 869-875
[75]
P. Venkatesan.
NICE guideline on long COVID.
Lancet Respir Med., (2021), 9 pp. 129
[76]
NIH. U.S. National Library of Medicine. Clinical Trials.gov [Internet]. EEUU. 2023 [Consultado 17 May 2023]. Disponible en: https://clinicaltrials.gov/ct2/results?cond=Long+COVID&term=&cntry=&state=&city=&dist=.
[77]
Y. Kim, S.E. Kim, T. Kim, K.W. Yun, S.H. Lee, E. Lee, et al.
Preliminary guidelines for the clinical evaluation and management of long COVID.
Infect Chemother., (2022), 54 pp. 566-597
[78]
K. Brown, A. Yahyouche, S. Haroon, J. Camaradou, G. Turner.
Long COVID and self-management.
Lancet., (2022), 399 pp. 355
[79]
J. Wright, S.L. Astill, M. Sivan.
The relationship between physical activity and long COVID: A cross-sectional study.
Int J Environ Res Public Health., (2022), 19 pp. 5093
[80]
World Health Organization. Clinical management of COVID-19: Living guideline. No. WHO/2019-nCoV/clinical/2023.1. World Health Organization, 13 Enero 2023. [Consultado 24 Jun 2023]. Disponible en: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2023.1.
[81]
I.M.Y. Prabawa, D. Silakarma, I.P.Y. Prabawa, I.B.A.P. Manuaba.
Physical rehabilitation therapy for long COVID-19 patient with respiratory sequelae: A systematic review.
Open Access Maced J Med Sci., (2022), 10 pp. 468-474
[82]
Long Covid Physio. 2020 [Consultado 17 May 2023]. Disponible en: https://es.longcovid.physio/.
[83]
K. Brehon, R. Niemeläinen, M. Hall, G.P. Bostick, C.A. Brown, M. Wieler, et al.
Return-to-work following occupational rehabilitation for long COVID: Descriptive cohort study.
JMIR Rehabil Assist Technol., (2022), 9 pp. e39883
[84]
R. Mathern, P. Senthil, N. Vu, T. Thiyagarajan.
Neurocognitive rehabilitation in COVID-19 patients: A clinical review.
South Med J., (2022), 115 pp. 227-231
[85]
Nikolich JŽ, C.J. Rosen.
Toward comprehensive care for long Covid.
N Engl J Med., (2023), 388 pp. 2113-2115
[86]
Y. Re’em, E.A. Stelson, H.E. Davis, L. MacCorkell, H. WEi, G. Assaf, et al.
Factors associated with psychiatric outcomes and coping in Long COVID.
Nat Mental Health., (2023), 1 pp. 361-372
[87]
A.W. Vaes, Y.M.J. Goërtz, M. van Herck, F.V.C. Machado, R. Meys, J.M. Delbressine, et al.
Recovery from COVID-19: A sprint or marathon?. 6-month follow-up data from online long COVID-19 support group members.
ERJ Open Res., (2021), 7 pp. 00141-2021
[88]
H.L.S. Day.
Exploring online peer support groups for adults experiencing long COVID in the United Kingdom: Qualitative interview study.
J Med Internet Res., (2022), 24 pp. e37674
[89]
J.C.R. Mullard, J. Kawalek, A. Parkin, C. Rayner, G. Mir, M. Sivan, et al.
Towards evidence-based and inclusive models of peer support for long covid: A hermeneutic systematic review.
Soc Sci Med., (2023), 320 pp. 115669
[90]
A. Aghaei, R. Zhang, S. Taylor, C.C. Tam, C.H. Yang, X. Li, et al.
Social life of females with persistent COVID-19 symptoms: A qualitative study.
Int J Environ Res Public Health., (2022), 19 pp. 9076
[91]
B. Bowe, Y. Xie, Z. Al-Aly.
Acute and postacute sequelae associated with SARS-CoV-2 reinfection.
Nat Med., (2022), 28 pp. 2398-2405
[92]
D. Ayoubkhani, C. Bermingham, K.B. Pouwels, M. Glickman, V. Nafilyan, F. Zaccardi, et al.
Trajectory of long covid symptoms after covid-19 vaccination: Community based cohort study.
BMJ., (2022), 14:377 pp. e069676
[93]
R. Perumal, L. Shunmugam, K. Naidoo, S.S. Abdool Karim, D. Wilkins, A. Garzino-Demo, et al.
Long COVID: A review and proposed visualization of the complexity of long COVID.
Front Immunol., (2023), 14 pp. 1117464
[94]
G. Torrell Vallespín, E. Martín Correa.
Sobre la organización asistencial del seguimiento a la COVID persistente.
FMC., (2022), 29 pp. 532-535
[95]
S. Barshikar, M. Laguerre, P. Gordon, M. Lopez.
Integrated care models for long coronavirus disease.
Phys Med Rehabil Clin N Am., (2023),
[96]
Z. Berger, V. Altiery de Jesus, S.A. Assoumou, T. Greenhalgh.
Long COVID and health inequities: The role of primary care.
Milbank Q, (2021), 99 pp. 519-541
[97]
T.F. Cavalcante, C.E. Lourenço, J.E.S.M. Ferreira, L.R. Oliveira, J.C. Neto, J.P. Amaro, et al.
Models of support for caregivers and patients with the post-COVID-19 condition: A scoping review.
Int J Environ Res Public Health., (2023), 20 pp. 2563
[98]
UK The NHS plan for improving long COVID services 2022 [Consultado 1 Jun 2023]. Disponible en: https://www.england.nhs.uk/wp-content/uploads/2022/07/C1607_The-NHS-plan-for-improving-long-COVID-services_July-2022.pdf.
[99]
Update on long COVID management - Health Information Portal.2022 [Consultado 4 Jun 2023] Disponible en: https://www.healthinformationportal.eu/sites/default/files/REF_Document/45_REF_minutes_questions_update_20221219.pdf.
[100]
NSW Agency for Clinical Innovation. Long COVID organizational model of care. Sydney: ACI; 2023 [Consultado 26 May 2023]. Disponible en: https://aci.health.nsw.gov.au/data/assets/pdf_file/0009/823068/ACI-Long-COVID-Model-of-Care.pdf.
[101]
Generalitat de Catalunya. Departament de Salut. Situació actual de la COVID-19 persistent a Catalunya. Càrrega estimada, recursos assistencials, experiències internacionals i àrees d’incertesa. Informe realitzat pel Comitè Científic Assessor de la COVID-19, el Grup Col·laboratiu Multidisciplinari per al Seguiment de la COVID i experts convocats ad-hoc per a aquest Informe. Enero 2023 [Consultado 27 May 2023].Disponible en: https://salutpublica.gencat.cat/web/.content/minisite/aspcat/sobre_lagencia/comite_assessor_covid19/230120_Informe-Long-Covid-.pdf.
[102]
J.B. Soriano, S. Murthy, J.C. Marshall, P. Relan, J.V. Diaz.
WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus.
Lancet Infect Dis., (2022), 22 pp. e102-e107
[103]
Boletín Oficial del Estado (BOE) (2020). Real Decreto 463/2020, de 14 de marzo, por el que se declara el estado de alarma para la gestión de la situación de crisis sanitaria ocasionada por el COVID-19 [Consultado 24 May 2023]. Disponible en: https://www.boe.es/eli/es/rd/2020/03/14/463.
[104]
A. González-Rodríguez, J. Labad.
Mental health in times of COVID: Thoughts after the state of alarm.
Med Clin (Barc)., (2020), 155 pp. 392-394
[105]
V.J. Clemente-Suárez, E. Navarro-Jiménez, J.A. Simón-Sanjurjo, A.I. Beltran-Velasco, C.C. Laborde-Cárdenas, J.C. Benitez-Agudelo, et al.
Information in COVID-19 health crisis: A narrative review.
Int J Environ Res Public Health., (2022), 19 pp. 5321
[106]
D. Hervalejo, R.J. Carcedo, N. Fernández-Rouco.
Familia y salud mental durante el confinamiento por la pandemia de COVID-19 en España: la perspectiva de los consejeros participantes en los servicios de atención psicológica.
J Comp Fam Stud., (2020), 51 pp. 399-416
[107]
A. Ammar, P. Mueller, K. Trabelsi, H. Chtourou, O. Boukhris, L. Masmoudi, et al.
Psychological consequences of COVID-19 home confinement: The ECLB-COVID19 multicenter study.
PLoS One., (2020), 15 pp. e0240204
[108]
A. Carfì, R. Bernabei, F. Landi, Gemelli Against COVID-19 Post-Acute Care Study Group.
Persistent symptoms in patients after acute COVID-19.
JAMA., (2020), 324 pp. 603-605
[109]
E. Long, S. Patterson, K. Maxwell, C. Blake, R. Bosó Pérez, R. Lewis, et al.
COVID-19 pandemic and its impact on social relationships and health.
J Epidemiol Community Health., (2022), 76 pp. 128-132
[110]
A. Bacigalupe, Y. González-Rábago, M. Jiménez-Carrillo.
Desigualdad de género y medicalización de la salud mental: factores socioculturales determinantes desde el análisis de percepciones expertas.
Aten Primaria., (2022), 54 pp. 102378
[111]
J. Ireson, A. Taylor, E. Richardson, B. Greenfield, G. Jones.
Exploring invisibility and epistemic injustice in long Covid-A citizen science qualitative analysis of patient stories from an online Covid community.
Health Expect., (2022), 25 pp. 1753-1765
[112]
X. Gimeno Torrent.
El circuito de la violencia simbólica en el síndrome de fatiga crónica (SFC)/encefalomielitis miálgica (EM)(I): un estudio preliminar.
Cuidado de la salud para la mujer internacional., (2022), 43 pp. 5-41
[113]
M. Samper-Pardo, B. Oliván-Blázquez, R. Magallón-Botaya, F. Méndez-López, C. Bartolomé-Moreno, S. León-Herrera.
The emotional well-being of long COVID patients in relation to their symptoms, social support and stigmatization in social and health services: a qualitative study.
BMC Psychiatry., (2023), 23 pp. 68
[114]
E.A. Byrne.
Understanding long Covid: Nosology, social attitudes and stigma.
Brain Behav Immun., (2022), 99 pp. 17-24
[115]
A. Ballering, T. Olde Hartman, J. Rosmalen.
Long COVID-19, persistent somatic symptoms and social stigmatisation.
J Epidemiol Community Health., (2021), 75 pp. 603-604
[116]
U. Scholz, W. Bierbauer, J. Lüscher.
Social stigma, mental health, stress, and health-related quality of life in people with long COVID.
Int J Environ Res Public Health., (2023), 20 pp. 3927
[117]
J. Van de Vyver, A.C. Leite, N.A. Alwan.
Navigating the social identity of long covid.
BMJ., (2021), 375 pp. n2933
[118]
A. Grimaldi.
Relación médico-paciente en la enfermedad crónica.
EMC-Tratado de Medicina., (2020), 24 pp. 1-6
[119]
A. Montalvo-Prieto, B. Cabrera-Nanclares, S. Quiñones-Arrieta.
Enfermedad crónica y sufrimiento: revisión de literatura.
Aquichan., (2012), 12 pp. 134-143
[120]
E.E. Chasco, K. Dukes, D. Jones, A.P. Comellas, R.M. Hoffman, A. Garg.
Brain fog and fatigue following COVID-19 infection: An exploratory study of patient experiences of long COVID.
Int J Environ Res Public Health., (2022), 19 pp. 15499
[121]
M. Hernán-García, J. Cubillo-Llanes, D. García-Blanco, R. Cofiño.
Epidemias, virus y activos para la salud del barrio.
Gac Sanit., (2020), 34 pp. 533-535
[122]
E.C. Martínez, R.R. Terán.
Salud comunitaria: Una revisión de los pilares, enfoques, instrumentos de intervención y su integración con la atención primaria.
JONNPR., (2021), 6 pp. 393-410
[123]
C. Lemhöfer, C. Sturm, D. Loudovici-Krug, N. Best, C. Gutenbrunner.
The impact of post-COVID-syndrome on functioning - results from a community survey in patients after mild and moderate SARS-CoV-2-infections in Germany.
J Occup Med Toxicol., (2021), 16 pp. 45
[124]
A. Fischer, L. Zhang, A. Elbéji, P. Wilmes, P. Oustric, T. Staub, et al.
Long COVID symptomatology after 12 months and its impact on quality of life according to initial coronavirus disease 2019 disease severity.
Open Forum Infect Dis., (2022), 9 pp. ofac397
[125]
Ministerio de Trabajo y Economía Social. Ministerio de Inclusión, Seguridad Social y Migraciones. Guía Laboral. Madrid; 2022 [Consultado 23 May 2023]. Disponible en: https://www.boe.es/biblioteca_juridica/abrir_pdf.php?id=PUB-DT-2022-251.
[126]
L. Kohn, M. Dauvrin, J. Detollenaere, C. Primus-de Jong, C. Maertens de Noordhout, D. Castanares-Zapatero, et al.
Long COVID and return to work: A qualitative study.
Occup Med (Lond)., (2022), pp. kqac119
[127]
US Department of Health and Human Services. Guidance on “long COVID” as a disability under the ADA, Section 504 and Section 1557. July 26, 202 [Consultado 27 May 23]. Disponible en: https://www.hhs.gov/civil-rights/for-providers/civil-rights-covid19/guidance-long-covid-disabi-lity/index.html.
[128]
Rayner C, Porter S, Begum F, Godderis L, Burton K, Fedson D, et al. Long COVID and return to work-what works? A position paper from the Society of Occupational Medicine. United Kingdom; 2022. Disponible en: https://www.som.org.uk/sites/som.org.uk/files/Long_COVID_and_Return_to_Work_What_Works.pdf.
[129]
Ministerio de Sanidad. Gobierno de España. Procedimiento de Actuación para los Servicios de Prevención de Riesgos Laborales frente a la exposición por SARS-COV-2. 2022 [Consultado 24 May 2023]. Disponible en: https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/Proteccion_Trabajadores_SARS-CoV-2.pdf.
[130]
Toro M. Fa més de cinquanta dies que tinc símptomes de COVID-19 i no remeten. Barcelona: Diari Ara; 10 de mayo de 2020 [Consultado 27 May 2023]. Disponible en: https://www.ara.cat/societat/cinquanta-dies-simptomes-covid19-coronavirus_1_1038661.html.
[131]
I. Alobid, P. Beltrán Troncoso, J. Blanch-Andreu, J. Fernández-Solà, J. Guarch, M. Garolera, et al.
Guia clínica per a l’atenció de les persones amb símptomes persistents de COVID-19.
Servei Català de la Salut, (2021),
[132]
Rodriguez Ledo P. Guía clínica para la atención al paciente long covid/covid persistente. Sociedad Española de médicos generales y de familia. Sociedad Española de Medicina General; 2021 [Consultado 27 May 2023]. Disponible en: https://www.semg.es/index.php/consensos-guias-y-protocolos/363-guia-clinica-para-la-atencion-al-paciente-long-covid-covid-persistente.
[133]
S. Epstein.
Impure science: AIDS, activism, and the politics of knowledge.
University of California Press;, (1996),
[134]
Hospital Germans Trias i Pujol. Unitat Covid Persistent. No t’ho inventes. Barcelona; 2020 [Consultado 27 May 2023]. Disponible en: https://www.nothoinventes.com/es/.
[135]
S. Guha Niyogi, R. Agarwal, V. Suri, P. Malhotra, D. Jain, G.D. Puri.
One minute sit-to-stand test as a potential triage marker in COVID-19 patients: A pilot observational study.
Trends Anaesth Crit Care., (2021), 39 pp. 5-9
[136]
A. Strassmann, C. Steurer-Stey, K.D. Lana, M. Zoller, A.J. Turk, P. Suter, et al.
Population-based reference values for the 1-min sit-to-stand test.
Int J Public Health., (2013), 58 pp. 949-953
[137]
L.A. Lorca, I. Leão Ribeiro, R. Torres-Castro, C. Sacomori, C. Rivera.
Propiedades psicométricas de la escala Post-COVID-19 Functional Status para adultos sobrevivientes de COVID-19.
Rehabilitacion (Madr)., (2022), 56 pp. 337-343
[138]
Escala de estado funcional post -COVID 19 versión en español (Chile). Julio 2020 [Consultado 18 Jun 2023]. Disponible en: https://www.studocu.com/es-mx/document/universidad-westhill/medicina-familiar-i/pcfs-version-espa-nol-chile/23461389.
[139]
G. Medinger, D. Altman.
The long COVID handbook.
Penguin Heath Handbooks;, (2022),
[140]
Miserandino C. The spoon theory. ButYouDon’tLookSick; 2003. [Consultado 27 May 2023]. Disponible en: https://butyoudontlooksick.com/articles/written-by-christine/the-spoon-theory/.
[141]
Interludio (Terapia Psicológica y Coaching). Teoría de las cucharas. Pinterest: Interludio; 2020 [Consultado 18 Jun 2023]. Disponible en: https://www.pinterest.cl/pin/995436323862536051/.
[142]
Garner P. COVID-19 at 14 weeks-phantom speed cameras, unknown limits and harsh penalties. BMJ Opinion. 2020 [Consultado 13 May 2023]. Disponible en: https://blogs.bmj.com/bmj/2020/06/23/paul-garner-covid-19-at-14-weeks-phantom-speed-cameras-unknown-limits-and-harsh-penalties/#:∼:text=You%20don’t%20know%20the,practically%2C%20psychologically%2C%20and%20spiritually.
[143]
Bateman Horne Center. Long COVID resources. NASA 10 Minute Lean Test. 2023 [Consultado 13 May 2023]. Disponible en: https://batemanhornecenter.org/wp-content/uploads/2016/09/NASA-Lean-Test-Instructions-1.pdf.
[144]
E. Shvartz, A. Meroz, A. Magazanik, Y. Shoenfeld, Y. Shapiro.
Exercise and heat orthostatism and the effect of heat acclimation and physical fitness.
Aviat Space Environ Med., (1977), 48 pp. 836-842
[145]
K.H. Hyatt, L.B. Jacobson, V.S. Schneider.
Comparison of 70 degrees tilt, LBNP, and passive standing as measures of orthostatic tolerance.
Aviat Space Environ Med., (1975), 46 pp. 801-808
[146]
EuroQol Group.
EuroQol: A new facility for the measurement of health-related quality of life.
Health Policy., (1990), 16 pp. 199-208
[147]
J.M. Guralnik, E.M. Simonsick, L. Ferrucci, R.J. Glynn, L.F. Berkman, D.G. Blazer, et al.
A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission.
J Gerontol., (1994), 49 pp. m85-m94
[148]
L. Rodríguez Mañas, A.J. Bayer, M. Kelly, A. Zeygang, M. Izquierdo, O. Laosa, et al.
An evaluation of the effectiveness of a multi-modal intervention in frail and pre-frail older people with type 2 diabetes - the MID-frail study: Study protocol for a randomised controlled trial.
Trials., (2014), 15 pp. 34
